Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$4.00 -0.10 (-2.44%)
As of: Nov 11, 2026 · 11:07 AM EST

Tonix Pharmaceuticals Holding (TNXP) Accumulated Expenses (2010 - 2024)

Updated

Tonix Pharmaceuticals Holding's Accumulated Expenses came in at $33,000 for Q2 2024.

Analysis

Tonix Pharmaceuticals Holding (TNXP) Accumulated Expenses (2010 - 2024) Analysis & Trends

At the end of FY2023, Tonix Pharmaceuticals Holding's Accumulated Expenses was $44,000.

  • Accumulated Expenses carries a five-year compound annual growth rate of -48.8% (FY2018 to FY2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Tonix Pharmaceuticals Holding 78.52 Mn -653.62 Mn 15.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 33,000.00
Dec 31, 2023 44,000.00
Sep 30, 2023 32,000.00
Dec 31, 2018 1.25 Mn
Sep 30, 2018 1.30 Mn
Jun 30, 2018 872,000.00
Mar 31, 2018 1.10 Mn
Dec 31, 2017 830,000.00
Sep 30, 2017 475,000.00
Jun 30, 2017 651,000.00
Mar 31, 2017 939,000.00
Dec 31, 2016 1.24 Mn
Sep 30, 2016 1.68 Mn
Jun 30, 2016 2.26 Mn
Mar 31, 2016 1.84 Mn
Dec 31, 2015 3.60 Mn
Sep 30, 2015 2.68 Mn
Jun 30, 2015 1.85 Mn
Mar 31, 2015 1.53 Mn
Dec 31, 2014 1.90 Mn
API Access

Tonix Pharmaceuticals Holding Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=TNXP&period=max&api_key=YOUR_API_KEY